Skip to Content
Merck
All Photos(1)

Documents

372951

Sigma-Aldrich

tert-Butyldimethylsilyl chloride solution

1.0 M in THF

Synonym(s):

tert-Butylchlorodimethylsilane solution, tert-Butyldimethylchlorosilane, tert-Butyldimethylsilyl chloride, TBDMSCl solution

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
(CH3)3CSi(CH3)2Cl
CAS Number:
18162-48-6
Molecular Weight:
150.72
Beilstein:
505999
MDL number:
MFCD00000501
UNSPSC Code:
12352103
PubChem Substance ID:
24863185
NACRES:
NA.22

form

liquid

concentration

1.0 M in THF

density

0.87 g/mL at 20 °C (lit.)
0.879 g/mL at 25 °C

SMILES string

CC(C)(C)[Si](C)(C)Cl

InChI

1S/C6H15ClSi/c1-6(2,3)8(4,5)7/h1-5H3

InChI key

BCNZYOJHNLTNEZ-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

related product

Product No.
Description
Pricing

19905

tert-Butyl(chloro)dimethylsilane, ≥95.0% (GC)

394882

N-tert-Butyldimethylsilyl-N-methyltrifluoroacetamide, >97%

190500

tert-Butyldimethylsilyl chloride, reagent grade, 97%

375934

N-tert-Butyldimethylsilyl-N-methyltrifluoroacetamide with 1% tert-Butyldimethylchlorosilane, ≥95%

473464

tert-Butylchlorodimethylsilane solution, 50 wt. % in toluene

384429

tert-Butyldimethylsilyl chloride solution, 1.0 M in methylene chloride

226149

tert-Butyldimethylsilyl trifluoromethanesulfonate, reagent grade, 98%

250236

1-(tert-Butyldimethylsilyl)imidazole, ≥95%

33092-U

tert-Butyldimethylsilylimidazole solution, TBDMSIM in DMF, pkg of 10 × 1 mL

06735

tert-Butyldimethylsilyl chloride, for GC derivatization, LiChropur™, ≥99.0% (GC)

56563

tert-Butyldimethylsilyl trifluoromethanesulfonate, for GC derivatization, LiChropur™, ≥98.0% (T)

77626

N-tert-Butyldimethylsilyl-N-methyltrifluoroacetamide, for GC derivatization, LiChropur™, ≥98.0% (GC)

00942

N-tert-Butyldimethylsilyl-N-methyltrifluoroacetamide with 1% tert-Butyldimethylchlorosilane, for GC derivatization, LiChropur™, ≥95.0% (GC)

44795

N,O-Bis(tert-butyldimethylsilyl)acetamide, for GC derivatization, LiChropur™, ≥98.0% (GC)

Signal Word

Danger

Hazard Classifications

Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Dam. 1 - Flam. Liq. 2 - Skin Corr. 1A - STOT SE 3

Target Organs

Central nervous system, Respiratory system

Supplementary Hazards

EUH019

Storage Class Code

3 - Flammable liquids

WGK

WGK 2

Flash Point(F)

1.4 °F - closed cup

Flash Point(C)

-17 °C - closed cup

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Akshanth R Polepally et al.
Journal of clinical pharmacology, 55(10), 1101-1108 (2015-04-24)
A classic 2-period crossover bioavailability study was conducted to evaluate the relative and absolute bioavailability of immediate-release (IR) and extended-release (XR) lamotrigine formulations under steady-state conditions in elderly patients with epilepsy. On treatment days, each subject's morning dose (IR or
P Huttenloch et al.
Environmental science & technology, 35(21), 4260-4264 (2001-11-23)
The efficacy of the surface modification of natural diatomite and zeolite material by chlorosilanes is demonstrated. Chlorosilanes used were trimethylchlorosilane (TMSCI), tert-butyldimethylchlorosilane (TBDMSCI), dimethyloctadecylchlorosilane (DMODSCI), and diphenyldichlorosilane (DPDSCI) possessing different headgroups and chemical properties. Silanol groups of the diatomite and
Some observations on the t-butyldimethylchlorosilane derivatization reaction.
K Bricknell et al.
Biochemical medicine, 23(1), 119-121 (1980-02-01)
Hiroaki Wakimoto et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 20(11), 2898-2909 (2014-04-10)
Isocitrate dehydrogenase (IDH) gene mutations occur in low-grade and high-grade gliomas. We sought to identify the genetic basis of malignant phenotype heterogeneity in IDH-mutant gliomas. We prospectively implanted tumor specimens from 20 consecutive IDH1-mutant glioma resections into mouse brains and
C Tellis et al.
Journal of biochemistry, 119(4), 823-827 (1996-04-01)
1-O-Hexadecyl-2-acetyl-sn-glycerol, the immediate precursor of platelet- activating factor (PAF) in its de novo formation, was detected in the protozoon Tetrahymena pyriformis. It was purified from the total lipid extract by TLC, after successive developments in two different solvent systems. Characterization
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service